SPOK — Spok Holdings, Inc · 2026-09-10 · Verdict: PASS · Conviction 3
Price $10.57 (screen row, priced 2026-09-10) · Mkt cap $221M · EV $204M · EV/normalised after-tax operating profit 13.5x (FY25) / 14.8x (LTM) · FCF yield 11.4% (CY2025) · Net cash $16.6M, no debt · ADV $1.7M Sources read: 10-K 2026-02-26 (Items 1, 1A, 7), 10-Q 2026-07-30, DEF 14A 2026-04-30, 8-Ks 2026-04-14, 2026-04-29, 2026-07-22, 2026-07-29, 2026-08-03, Form 4s (12m). No transcript or prepared remarks were filed; the earnings release is the closest SEC-sourced substitute.
Desk stats - Revenue trend. FY2025 revenue $139.708M, up 1.5%; wireless $72.522M down 1.4%, software $67.186M up 4.8% (10-K 2025, Item 7). Q2 2026 revenue $35.011M, down 1.9%; first half $68.237M, down 5.2% (10-Q Q2 2026, Item 2). The driver is price offsetting volume: paging units fell 720k to 675k to 645k while ARPU rose $7.97 to $8.20 on September 2024 and 2025 rate increases (10-K 2025, Item 7; 8-K 2026-07-29). - Normalised after-tax operating profit. FY2025 GAAP operating income $19.710M. Adjustments: add severance and restructuring $0.458M (10-K 2025, Item 7); no goodwill or long-lived impairment in 2023, 2024 or 2025 (10-K 2025, Item 7, Critical Accounting Estimates); no discontinued operations; the $0.7M domain-name gain sits in other income, not operating income, so it is not added back. Normalised operating income $20.168M against $19.710M GAAP, taxed at 25% gives $15.126M. On the twelve months to 30 June 2026 the same build gives $18.4M, or $13.8M after tax. - EV / normalised after-tax profit. 20,905,932 shares (8-K 2026-07-22) at $10.57 is $221.0M, less $16.592M cash and no debt (10-Q balance sheet), so EV is $204.4M: 13.5x on FY2025, 14.8x on LTM, about 13.2x on the 2026 guide of $30M adjusted EBITDA less roughly $5.4M stock compensation and $3.9M depreciation at first-half run rates. - Leverage. No debt. Net cash $16.6M, about 0.7x normalised EBITDA of $23.6M. Off balance sheet sit $5.746M of operating lease liabilities and $4.955M of asset retirement obligations for transmitter sites (10-Q balance sheet). - Is the growth sustainable? No. It is organic but it has stopped: on 29 July management cut 2026 revenue guidance to $132.5-139.5M from $136.0-143.0M, a $136M midpoint against $139.7M delivered in 2025, while holding the adjusted EBITDA midpoint at $30M (8-K 2026-07-29). - What the screen got wrong. The screen is right that there is no debt, and its "debt data missing" flag resolves in the company's favour. It got the growth gate wrong: it qualified SPOK on FY2025 figures the company's own guidance has since reversed. It also treats FY2025's $27.3M of dividends as covered by the $25.2M of free cash flow they exceeded.
1. What the business actually does
Two halves of roughly equal size pointing in opposite directions. Wireless is the largest paging carrier in the United States, about 645 thousand pagers across roughly 2,000 hospitals at $8.20 a month (8-K 2026-08-03). Software is Spok Care Connect, an on-premise contact-centre, on-call scheduling and clinical alerting suite sold as licences with maintenance, professional services and managed services (10-K 2025, Item 7). Healthcare is over 85% of revenue, average tenure with the U.S. News "Best Hospitals" is 26 years, and no customer exceeds 10% of revenue (10-K 2025, Item 1). 421 employees at end-2025, 382 at 30 June 2026.
2. Why it is mispriced — the edge case
There is not one. No spin, no index deletion, no restatement, no forced seller. The register is ordinary: BlackRock 6.75%, Braeside 5.10%, Renaissance 5.06%, all directors and officers 7.28% (DEF 14A 2026-04-30). Volume is $1.7M a day and the stock is 33% off its high after closing 2025 at $13.19 (DEF 14A). The one real signal is insider buying: director Todd Stein, co-manager of the 5.10% Braeside holding, bought 35,211 shares at $10.4145 on 2026-06-16, and CEO Vincent Kelly bought 10,000 at about $10.68 on 11 and 12 May (Form 4s). Against that, the corporate secretary and treasurer sold 20,000 shares at $11.297 on 2026-08-10, leaving 6,036 (Form 4). Absent an edge case the verdict is capped at WATCH; the numbers below take it lower.
3. Unit economics and growth
Wireless is a decline that has been managed well: technology operations expense fell 4.0% in 2025 as active transmitters fell 5.9%, and 3.1% again in the first half (10-K 2025, Item 7; 10-Q). But attrition now runs at 7.1% year over year and the price lever looks spent, with ARPU flat at $8.20 in Q2 against Q2 2025 and down from $8.29 in Q1 (8-K 2026-07-29).
Software, the half meant to grow, is going backwards on the leading indicators. First-half bookings were $14.406M against $19.998M, down 28.0%, and backlog $57.108M against $65.187M, down 12.4% (8-K 2026-07-29). Quality worsened too: that backlog excludes $17.0M of obligations cancellable without significant penalty against $10.1M a year earlier, so cancellable commitments grew 68% while committed backlog shrank. The Q2 headline of bookings "up nearly 92% from the prior quarter" measures against a Q1 that booked $4.9M; year over year, Q2 bookings fell 18.8%.
Profit is held by cost cuts, not volume. The April realignment cut about 10% of the workforce for over $6.0M of annualised savings (10-Q, Business), yet first-half operating income still fell 31.0% to $7.869M and adjusted EBITDA 8.2% to $14.400M, so the $30M guide needs $15.6M in the second half. Cash conversion is genuinely good while it lasts: only $0.309M of income tax was paid in the first half, shielded by a $34.955M net deferred tax asset.
4. Balance sheet and capital allocation
Here the case fails. The dividend is $1.25 a year, about $26.2M, an 11.8% yield. FY2025 free cash flow was $25.2M ($28.949M operating less $3.753M capex) against $27.3M of distributions plus $2.8M spent buying stock for tax withholding (10-K 2025, Item 7). Cash fell $29.145M to $25.280M in 2025 and to $16.592M by 30 June, with first-half operating cash flow of $8.922M against $14.494M of distributions (8-K 2026-07-29). The $8.0M spectrum sale to Sensus USA, closed 20 July with a pre-tax gain near $7.5M, plugs about two quarters and is not repeatable at will (10-Q, Liquidity). The $10M repurchase authorisation from February 2022 is untouched while the share count grows about 1.6% a year, and the August deck still guides to "2026 capital return >$27 million anticipated" (8-K 2026-08-03).
5. Management: what they said vs what they did
On 29 April, three weeks after announcing the realignment, Kelly reiterated full-year guidance (8-K 2026-04-29). Thirteen weeks later the revenue range was cut $3.5M at both ends while the EBITDA midpoint was held (8-K 2026-07-29). The long-term incentive plan is weighted 100% to cumulative adjusted EBITDA, which excludes both stock compensation and the severance the realignment created, and paid 130% for 2023-2025 (DEF 14A 2026-04-30). Holding EBITDA while cutting revenue is precisely what the pay plan rewards. The realignment also removed the CFO: Calvin Rice was replaced on 14 April by COO Michael Wallace, who now holds both roles (8-K 2026-04-14, Item 5.02).
6. Valuation
Sustainable cash to owners is roughly $23.5M: $30M guided adjusted EBITDA less about $3M capex, $1M cash tax and $2.5M of annual share purchases for tax withholding, a 10.6% yield. Base case, revenue declining 2.5% a year with margins held by network rationalisation, capitalises that at 10% less minus 2.5% for about $188M, or $9.00 a share (45%). Bear, decline steepens to 5% and the dividend is cut, triggering mechanical selling on a yield-owned register: about $157M, or $7.50 (30%). Bull, the $6M of savings and AI efficiency stabilise revenue near flat and bookings recover: about $245M, or $11.70 (25%). Probability-weighted $9.23, roughly 13% below price. Reverse DCF: at a 10% discount rate the $204M enterprise value against $15.5M of normalised after-tax operating profit implies about 2.4% perpetual growth, from a company guiding this year's revenue down 2.7% with 52% of it in structural 6-7% annual decline.
7. Catalysts and timeline
Q3 in late October is the dated test: whether the second half delivers the $15.6M of adjusted EBITDA the guide needs, whether bookings recover, and whether the $7.5M spectrum gain shows up as cash rather than being consumed. The Q4 goodwill test matters if the price falls further, since fair value is estimated from the company's own share price and $99.175M of goodwill sits against $139.867M of equity. The February 2027 dividend declaration is the real event.
8. Risks and pre-registered kill criteria
- Cash below $12M at any quarter end without a matching one-off asset sale — the dividend is then being paid from the balance sheet.
- Software bookings down year over year for a third consecutive quarter, or backlog below $52M.
- The quarterly dividend cut or suspended, or the annualised payout below $20M.
- Wireless units declining more than 2.5% in a single quarter, against 1.8% in Q2 2026. Any of the first three confirms the thesis; a reversal of 2 and 4 together with cash stable would be the case for revisiting.
9. Verdict and one-paragraph summary
PASS, conviction 3. Spok is a well-run, debt-free, 80%-recurring healthcare communications business with a blue-chip hospital base and an 11.8% dividend yield, and the screen's "debt data missing" flag resolves in its favour, but the screen qualified it on a growth gate its own current filings no longer pass: management cut 2026 revenue guidance on 29 July to a $136M midpoint against $139.7M delivered in 2025, first-half revenue fell 5.2% and operating income 31%, software bookings fell 28% with backlog down 12.4% and the cancellable obligations excluded from it up 68%, and wireless units are shrinking 7.1% a year now the ARPU lever has gone flat. The roughly $26M dividend has exceeded free cash flow two years running, which is why cash fell from $29.1M to $16.6M in eighteen months and why an $8M one-off spectrum sale was needed to plug the gap, while a $10M buyback authorisation sits untouched since 2022 and the pay plan rewards the adjusted EBITDA midpoint management held by cutting 10% of the workforce. At $10.57 the enterprise value implies about 2.4% perpetual growth against guided decline, probability-weighted value is around $9.23, and two genuine insider buys at $10.41 and $10.68 do not buy a shrinking earnings stream funding an uncovered distribution.
Research for discussion, not investment advice. Positions and sizing are the reader's decision.